Covered recipient · General Payments record
LYDIA SAUER
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2021–2024
$3,209.29
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,407.42 | 3 |
| Food and Beverage | $1,090.43 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $1,881.74 | 7 |
| Alimera Sciences, Inc. | $236.98 | 2 |
| NEW WORLD MEDICAL,INC. | $161.63 | 4 |
| Apellis Pharmaceuticals, Inc. | $107.10 | 1 |
| ABBVIE INC. | $59.85 | 1 |
| Dutch Ophthalmic, USA | $50.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $59.85 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106024507 | CMS |
| Alcon Vision LLC | $141.76 | 03/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718163 | CMS |
| Alcon Vision LLC | $31.26 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718159 | CMS |
| Alcon Vision LLC | $36.51 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718161 | CMS |
| Alcon Vision LLC | $352.39 | 11/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110529902 | CMS |
| Alcon Vision LLC | $524.27 | 11/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110529904 | CMS |
| Alcon Vision LLC | $530.76 | 11/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110529906 | CMS |
| Alcon Vision LLC | $264.79 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718165 | CMS |
| Alimera Sciences, Inc. | $92.00 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092825192 | CMS |
| Alimera Sciences, Inc. | $144.98 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092838329 | CMS |
| Apellis Pharmaceuticals, Inc. | $107.10 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154025263 | CMS |
| Dutch Ophthalmic, USA | $50.55 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154792154 | CMS |
| NEW WORLD MEDICAL,INC. | $8.57 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137396352 | CMS |
| NEW WORLD MEDICAL,INC. | $43.62 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137399829 | CMS |
| NEW WORLD MEDICAL,INC. | $54.72 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137400477 | CMS |
| NEW WORLD MEDICAL,INC. | $54.72 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137401123 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.